(Q44086481)

English

Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation

scientific article published on 25 September 2014

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

0 references

Chinten James Lim

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Nico van Rooijen

13

object named as

Nico van Rooijen

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

object named as

Lisa K Kozicky

2

0 references

author name string

Shelley B Weisser

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hayley K Brugger

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Eyler N Ngoh

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Bonnie Cheung

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Roger Jen

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Susan C Menzies

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Asanga Samarakoon

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Peter J Murray

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Pauline Johnson

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jean-Luc Boucher

12

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

25 September 2014

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

3353-3367

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Crucial steps in the natural history of inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Inflammatory bowel disease: a Canadian burden of illness review

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

State-of-the-art: Immunosuppression and biologic therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Dextran sodium sulphate colitis mouse model: traps and tricks

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Chemically induced mouse models of intestinal inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

The role of macrophages in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Alternative activation of macrophages: an immunologic functional perspective

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Macrophage plasticity and polarization: in vivo veritas

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Macrophage polarization in health and disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Alternative activation of macrophages by IL-4 requires SHIP degradation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

PI3K inhibition in inflammation: Toward tailored therapies for specific diseases.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Phosphoinositide 3-kinase delta (PI3Kδ) in leukocyte signaling and function

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Altered macrophage function contributes to colitis in mice defective in the phosphoinositide-3 kinase subunit p110δ.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Suppression of experimental colitis by intestinal mononuclear phagocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Generation and characterization of murine alternatively activated macrophages

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

SHIP-deficient mice develop spontaneous intestinal inflammation and arginase-dependent fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Trichuris suis therapy in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Induction of arginase I transcription by IL-4 requires a composite DNA response element for STAT6 and C/EBPbeta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Enhancer-mediated control of macrophage-specific arginase I expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Role of phosphoinositide 3-kinase in innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) increases the expression of prostaglandin E2 receptor subtype EP4. The roles of phosphatidylinositol 3-kinase and CCAAT/enhancer-binding protein beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Protective role of arginase in a mouse model of colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Safety and tolerability of a modified filter‐type device for leukocytapheresis using ACD‐A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Long-term follow-up with Granulocyte and Monocyte Apheresis re-treatment in patients with chronically active inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Selective depletion of peripheral granulocyte/monocyte enhances the efficacy of scheduled maintenance infliximab in Crohn's disease

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Regulatory macrophages: setting the threshold for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Obstacles and opportunities for understanding macrophage polarization

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

21 January 2018

The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

7 January 2021

based on heuristic

inferred from DOI database lookup

DSS-induced colitis is exacerbated in STAT-6 knockout mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of arginase ameliorates experimental ulcerative colitis in mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201343981

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201343981

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44086481&oldid=2106447785"